Press release
Anti-Inflammatory Therapeutics Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033
Anti-Inflammatory Therapeutics Market
The Business Research Company's Anti-Inflammatory Therapeutics Global Market Report 2023 identifies the rising prevalence of autoimmune disorders as the major driver for the anti-inflammatory therapeutics market's growth in the forecast period. Autoimmune disorders refer to a group of medical conditions in which the immune system, which is responsible for protecting the body from harmful invaders like bacteria and viruses, mistakenly targets and attacks the body's own healthy cells and tissues. The rising prevalence of autoimmune disorders is a significant factor in the growth of anti-inflammatory therapeutics. These therapeutics are commonly used to treat autoimmune disorders. These medications aim to reduce inflammation, control the immune system's overactive response, and alleviate the symptoms associated with autoimmune conditions.
The anti-inflammatory therapeutics market size has grown steadily in recent years. It will grow from $109.88 billion in 2023 to $114.71 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, increased awareness, and government initiatives.
The anti-inflammatory therapeutics market size is expected to see steady growth in the next few years. It will grow to $135.6 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to innovative therapies, increasing healthcare expenditure, focus on rare diseases, biologics and biosimilars. Major trends in the forecast period include advancements in immunotherapy, artificial intelligence (AI) and machine learning (ML) in drug discovery, expansion of indications.
Download Free Sample Of Anti-Inflammatory Therapeutics Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=12861&type=smp
Major competitors in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
A key trend in the anti-inflammatory therapeutics market includes increasing prevalence of inflammatory bowel disease. Anti-inflammatory therapeutics play a crucial role in treating Crohn's disease by reducing inflammation, managing the symptoms of the disease, and reducing the risk of surgery. For instance, in July 2023, according to Oxford University Press (OUP), the university press of the University of Oxford, incidence of inflammatory bowel disease (IBD) is 10.9 per 100,000 person-years and the prevalence is 721 per 100,000 people. Therefore, the increasing prevalence of inflammatory bowel disease is driving the growth of the anti-inflammatory therapeutics market
Read More On The Global Anti-Inflammatory Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report
The anti-inflammatory therapeutics market is segmented -
• By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
• By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
• By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the anti-inflammatory therapeutics market.
The Business Research Company's "Global Anti-Inflammatory Therapeutics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Anti-Inflammatory Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12861
The Table Of Content For The Anti-Inflammatory Therapeutics Market Include:
1. Executive Summary
2. Anti-Inflammatory Therapeutics Market Characteristics
3. Anti-Inflammatory Therapeutics Market Trends And Strategies
4. Anti-Inflammatory Therapeutics Market - Macro Economic Scenario
……
32. Global Anti-Inflammatory Therapeutics Market Competitive Benchmarking
33. Global Anti-Inflammatory Therapeutics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Anti-Inflammatory Therapeutics Market
35. Anti-Inflammatory Therapeutics Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Inflammatory Therapeutics Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033 here
News-ID: 3323955 • Views: …
More Releases from The Business research company
Top Market Shifts Transforming the Asphalt And Concrete Equipment Market Landsca …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Asphalt And Concrete Equipment Market Through 2025?
During the past few years, there has been significant expansion in the asphalt and concrete equipment market. It is predicted to increase from $11.82 billion in 2024 to $12.54 billion in 2025, witnessing a compound…
Surge In Renovation And Retrofit Projects Fueling The Growth Of The Market Due T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Architectural Lighting Fixture Market Through 2025?
The market size for architectural lighting fixtures has seen a significant boost in recent years. The estimated progression is from $45.01 billion in 2024 to $47.87 billion in 2025, exhibiting a compound annual growth rate (CAGR)…
2025-2034 Aluminum Metal Fencing Market Evolution: Disruptions, Innovations, and …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Aluminum Metal Fencing Market Through 2025?
The market size for aluminum metal fencing has greatly expanded in the past few years. It is projected to rise from $4.31 billion in 2024 to $4.61 billion in 2025, with a compound annual growth rate…
Soaring Demand Set to Propel Adventure Travel Insurance Market to $3.56 Billion …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Adventure Travel Insurance Market Through 2025?
In recent times, the market size for adventure travel insurance has witnessed solid growth. From a value of $2.34 billion in 2024, it is projected to reach $2.55 billion in 2025. This progression indicates a compound…
More Releases for Inflammatory
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
The Anti-Inflammatory Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Anti-Inflammatory Therapeutics Market Size and Projected Growth Rate?
The market size of anti-inflammatory therapeutics has shown a consistent growth in the past few years. The market is projected to expand from $114.71…
Rising Incidence Of Inflammatory Bowel Disease Fuels Growth In The Anti-Inflamma …
What market dynamics are playing a key role in accelerating the growth of the anti-inflammatory therapeutics market?
As inflammatory bowel disease becomes more commonplace, it is predicted to encourage progress in the anti-inflammatory therapeutics market. Characterized as a long-term condition causing inflammation of the digestive tract, inflammatory bowel disease (IBD) is effectively managed with the usage of anti-inflammatory therapeutics. These treatments are central in the control of Crohn's disease via decreasing…
Inflammatory Bowel Disease Market: Trends and Outlook
The inflammatory bowel disease (IBD) treatment market is projected to expand from USD 19.91 billion in 2023 to approximately USD 33.19 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.5% between 2024 and 2032.
Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149
Understanding the Rising Impact of Inflammatory Bowel Disease (IBD) and Advances in Crohn's Disease Research
Inflammatory Bowel Disease (IBD), which includes Crohn's disease and ulcerative colitis, continues to rise globally, posing…
Anti-Inflammatory Activity Enzyme Manufacturer | Pearlzyme Inc
Pearlzyme Inc. is a South Korean company that manufactures anti inflammatory activity enzymes. This anti-inflammatory activity enzyme boosts the animal's immune system against infection and increases milk lactation.
Pearlzyme Inc. is committed to providing high-quality products and services to its customers. The company has a team of experienced scientists and engineers who are constantly working to develop new and innovative products. Pearlzyme Inc. is also committed to sustainable development and is…
Inflammatory Bowel Disease Market: The Present and Future of Inflammatory Bowel …
Stratagem Market Insights have included the latest addition of a global market research report titled Inflammatory Bowel Disease Market tits expansive repository. The report studies primary and secondary research in order to analyze the data effectively. The market study further draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant…
Rising incidences of chronic inflammatory and autoimmune diseases has increased …
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.
Get the sample…
